London-based Lindus Health, which has built a software platform for running clinical trials, raised a $55M Series B led by Balderton Capital — A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.”
Posted from: this blog via Microsoft Power Automate.
